Â鶹ֱ²¥app

Stroke and Stroke Rehabilitation: Discharged on Antithrombotic Therapy

Percentage of patients aged 18 years and older with a diagnosis of ischemic stroke or transient ischemic attack (TIA) who were prescribed antithrombotic therapy at discharge.

Date Reviewed: November 19, 2017

Measure Info

MIPS 032 NQF 0325 CMS 032 NQF Endorsement Removed
Measure Type
Process
Measure Steward
American Academy of Neurology
Clinical Topic Area
Stroke

Care Setting
Inpatient
Data Source
Claims
Registry

ACP supports QPP 032: "Stroke and Stroke Rehabilitation: Discharged on Antithrombotic Therapy" because the measure aligns with the principles of high value care and contributes to improved clinical outcomes as the survivors of a stroke or transient ischemic attack are at increased risk of a subsequent stroke. High-quality evidence exists to support the use of antithrombotic agents for the prevention of a second ischemic stroke in patients who survive an ischemic stroke or transient ischemic attack. We note; however, that the measure specifications do not distinguish among the available antithrombotics, which may encourage prescription of expensive medications. Developers should consider revising the specifications to guide clinicians in making pharmacologic treatment choices that are optimal both clinically and in terms of cost.